Search Results - "Lundgren, Kevin T."

Immunotherapy in Urothelial Cancer: Recent Results and Future Perspectives by Farina, Matthew S., Lundgren, Kevin T., Bellmunt, Joaquim

“…Cytotoxic chemotherapy has been the only systemic treatment of locally advanced and metastatic urothelial carcinoma for decades. Long-term survival remains…”
Get full text

Pembrolizumab in the treatment of advanced urothelial cancer by Lundgren, Kevin T, Farina, Matthew S, Bellmunt, Joaquim

“…Pembrolizumab is a humanized monoclonal antibody that targets PD-1. In the Phase III trial KEYNOTE-045, pembrolizumab was associated with a significant overall…”
Get full text

Cell-free tumor DNA and TERT promoter mutations in bladder cancer by Huang, Franklin W., Rinne, Mikael L., Lundgren, Kevin T., Mullane, Stephanie Anne, Moreno, Irene, Reed, Sarah, Gydush, Greg, Adalsteinsson, Viktor, Novak, Jesse, Hahn, William C., Signoretti, Sabina, Choueiri, Toni K., Garraway, Levi A., Bellmunt, Joaquim

“…Abstract only 353 Background: Currently, there are no FDA-approved blood biomarkers for the prognosis or prediction of outcomes in urothelial carcinoma (UC)…”
Get full text